Dallas TX 心房颤动临床试验
9项针对 心房颤动的研究正在 Dallas及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
招募中3 期
- University of Texas Southwestern Medical Center, Dallas
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
招募中观察性研究
- Baylor Scott & White Research Institute, Dallas
- Medical City Dallas Hospital, Dallas
The Fourth Left Atrial Appendage Occlusion Study
招募中
- Baylor Research Institute, Dallas
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
招募中3 期
- Southwest Family Medicine Associates, Dallas
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
招募中
- Texas Cardiac Arrhythmia Research Foundation, Dallas
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
招募中3 期
- Anthos Investigative Site 9943, Dallas
- Anthos Investigative Site 9942, Dallas
BoxX-NoAF Clinical Trial
招募中欢迎健康志愿者
- Baylor Research Institute - Baylor Scott and White Research Institute, Dallas
Get With the Guidelines Atrial Fibrillation Registry
招募中观察性研究欢迎健康志愿者
- Amy Bennett, Dallas
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
招募中观察性研究
- UT Southwestern Medical Center, Dallas
其他城市的 心房颤动试验
- New York City, NY21 项研究
- Cleveland, OH17 项研究
- Boston, MA17 项研究
- Atlanta, GA16 项研究
- Jonesboro, AR12 项研究
- Chicago, IL12 项研究
- Philadelphia, PA12 项研究
- Ann Arbor, MI11 项研究
- Cincinnati, OH10 项研究
- Columbus, OH10 项研究
- Pittsburgh, PA10 项研究
- Orlando, FL9 项研究
Dallas的其他研究
- 乳腺癌55 项研究
- 非小细胞肺癌52 项研究
- 转移性癌症42 项研究
- 心力衰竭42 项研究
- 癌症（所有类型）37 项研究
- 前列腺癌36 项研究
- 结直肠癌33 项研究
- 肥胖症30 项研究
- 卵巢癌28 项研究
- 肺癌27 项研究
- 膀胱癌27 项研究
- 子宫内膜癌24 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。